WPRIM Management System> DCMS> Tumor> 2011> 31> 10

Volume: 31 Issue: 10

1. Anti-angiogenesis effect of adeno-associated virus-mediated recombinant angiostatin combined with celastrol on intracranial C6 glioma in rats Page:875—880
2. Tumorigenesis of bone marrow stromal cells transplanted into the brain of Sprague-Dawley rats: Report of three cases Page:881—885
3. The downregulation of HDAC2 expression in esophageal squamous cell carcinoma and its effect on biological features of EC9706 cells Page:886—892
4. Reversion of multidrug resistance in leukemia K562 cells by RNA interference targeting homeobox A10 gene Page:893—898
5. Effects of geldanamycin on cell proliferation and apoptosis of human ovarian cancer cell line SKOV3 and their mechanism Page:899—905
6. Isolation and culture of cancer stem cells from ovarian cancer tissues and malignant ascites Page:906—910
7. Venous thromboembolism in 89 patients with lung cancer: Clinical analysis Page:911—917
8. Analysis of clinicopathological features and prognostic factors of 1 081 patients with locally advanced breast cancer Page:918—923
9. Clinical value of methylation of plasma adenomatous polyposis coli gene in the molecular diagnosis of hepatocellular carcinoma Page:924—929
10. The role of pharmacokinetic monitoring of fluorouracil in improvement of efficacy and reduction of adverse reactions for patients with advanced gastric cancer Page:930—936
11. The expression levels of Reg4 and Ki67 in superficial elevated mucosa lesions of atrophic gastritis with intestinal metaplasia are higher than those in superficial depressed mucosa lesions Page:937—941
12. Expression of CIP2A in non-small cell lung cancer and its clinical significance Page:942—945
13. Clinical analysis of 11 patients with bilateral primary breast lymphoma Page:946—949
14. Molecular markers associated with anti-EGFR monoclonal antibody in treatment selection for advanced colorectal cancer Page:950—956
15. Role of abnormal expression of receptor for advanced glycosylation end products in carcinogenesis, tumor invasion, and metastasis Page:957—960
16. Chemokine CCL20 and malignant tumors Page:961—963